Leo Pharma May Delay IPO to 2027
Danish drugmaker Leo Pharma is considering delaying its planned initial public offering until 2027. Ongoing turmoil in global financial markets prompted the potential postponement, according to reports.
Market Turmoil Threatens Listing Timeline
Denmark-based Leo Pharma is considering pushing its IPO to 2027, delaying a planned public listing. The drugmaker is weighing the move amid ongoing turbulence in global financial markets, local daily Berlingske reported on Friday morning, citing unnamed sources. Investors watch the potential delay as a bellwether for European healthcare equity valuations.
